The natural product industry is booming and showing no signs of slowing. Big brands are taking note by scooping up smaller, innovative companies that are disrupting consumer products by adding a natural twist. Michael Cammarata, Co-Founder and CEO of Schmidt's Naturals, shared why his company was such an attractive target for Unilever.
Cammarata said Unilever was drawn to his brand due to its rapid growth and ability to go to market quickly. He said consumers have been the brands biggest advocate. The entrepreneur also added that the Unilever focuses on the founders and allows them to continue to operate the way they want.
All-natural has been all the rage as consumers increasingly opt for chemical-free products. He says his brand is unique because they focused on competing with brands in the traditional space. He added consumers are realizing products with natural ingredients are delivering similar results as the initial products.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
Shopping expert Trae Bodge discusses how talks between the U.S. and China is good news for now, but uncertainty remains for back-to-school and the holidays.
Jake Traylor, White House reporter at Politico, joins Cheddar to discuss how Trump is aiming to lower drug prices and how it differs from Biden's approach.
